Antibiotice Ia (ATB) — Cash Flow Quality Index
Antibiotice Ia (ATB) has a Cash Flow Quality Index of -3.13x as of March 2026. Operating cash flow of RON-39.31 Million is below net income of RON12.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Antibiotice Ia to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Antibiotice Ia Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Antibiotice Ia across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Antibiotice Ia (ATB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Antibiotice Ia (2022–2025)
Year-by-year earnings quality comparison for Antibiotice Ia. For live market cap and the full company financial profile, see Antibiotice Ia stock valuation.
| Year | Quality Index | Operating CF (RON) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.40x | RON72.44 Million | RON51.77 Million | ▲ +46.2% |
| 2024 | 0.96x | RON95.15 Million | RON99.42 Million | ▼ -36.6% |
| 2023 | 1.51x | RON122.46 Million | RON81.09 Million | ▼ -49.7% |
| 2022 | 3.00x | RON115.66 Million | RON38.51 Million | — |